{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:45:52Z","timestamp":1791902752315,"version":"4.3.4"},"reference-count":98,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Institutional Animal Ethics Committee (IAEC)","award":["573\/PO\/Re\/S\/02\/CPCSEA"],"award-info":[{"award-number":["573\/PO\/Re\/S\/02\/CPCSEA"]}]},{"name":"Institutional Animal Ethics Committee (IAEC)","award":["RSP2022R491"],"award-info":[{"award-number":["RSP2022R491"]}]},{"name":"King Saud University, Riyadh, Saudi Arabia","award":["573\/PO\/Re\/S\/02\/CPCSEA"],"award-info":[{"award-number":["573\/PO\/Re\/S\/02\/CPCSEA"]}]},{"name":"King Saud University, Riyadh, Saudi Arabia","award":["RSP2022R491"],"award-info":[{"award-number":["RSP2022R491"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Huntington\u2019s disease (HD) is distinguished by a triple repeat of CAG in exon 1, an increase in poly Q in the Htt gene, and a loss of GABAergic medium spiny neurons (MSN) in the striatum and white matter of the cortex. Mitochondrial ETC-complex dysfunctions are involved in the pathogenesis of HD, including neuronal energy loss, synaptic neurotrophic decline, neuronal inflammation, apoptosis, and grey and white matter destruction. A previous study has demonstrated that beta Boswellic acid (\u03b2-BA), a naturally occurring phytochemical, has several neuroprotective properties that can reduce pathogenic factors associated with various neurological disorders. The current investigation aimed to investigate the neuroprotective potential of \u03b2-BA at oral doses of 5, 10, and 15 mg\/kg alone, as well as in conjunction with the potent antioxidant vitamin E (8 mg\/kg, orally) in 3-NP-induced experimental HD rats. Adult Wistar rats were separated into seven groups, and 3-NP, at a dose of 10 mg\/kg, was orally administered to each group of adult Wistar rats beginning on day 1 and continuing through day 14. The neurotoxin 3-NP induces neurodegenerative, g, neurochemical, and pathological alterations in experimental animals. Continuous injection of 3-NP, according to our results, aggravated HD symptoms by suppressing ETC-complex-II, succinate dehydrogenase activity, and neurochemical alterations. \u03b2-BA, when taken with vitamin E, improved behavioural dysfunctions such as neuromuscular and motor impairments, as well as memory and cognitive abnormalities. Pharmacological treatments with \u03b2-BA improved and restored ETC complexes enzymes I, II, and V levels in brain homogenates. \u03b2-BA treatment also restored neurotransmitter levels in the brain while lowering inflammatory cytokines and oxidative stress biomarkers. \u03b2-BA\u2019s neuroprotective potential in reducing neuronal death was supported by histopathological findings in the striatum and cortex. As a result, the findings of this research contributed to a better understanding of the potential role of natural phytochemicals \u03b2-BA in preventing neurological illnesses such as HD.<\/jats:p>","DOI":"10.3390\/biomedicines10112866","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T02:03:58Z","timestamp":1668045838000},"page":"2866","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Beta-Boswellic Acid Reverses 3-Nitropropionic Acid-Induced Molecular, Mitochondrial, and Histopathological Defects in Experimental Rat Model of Huntington\u2019s Disease"],"prefix":"10.3390","volume":"10","author":[{"given":"Thamer H.","family":"Albekairi","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzoo","family":"Kamra","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Seth G.L. Bihani S.D. College of Technical Education, Institute of Pharmaceutical Sciences and Drug Research, Sri Ganganagar 335001, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Bhardwaj","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Seth G.L. Bihani S.D. College of Technical Education, Institute of Pharmaceutical Sciences and Drug Research, Sri Ganganagar 335001, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0034-835X","authenticated-orcid":false,"given":"Sidharth","family":"Mehan","sequence":"additional","affiliation":[{"name":"Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy (An Autonomous College), Moga 142001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Giri","sequence":"additional","affiliation":[{"name":"Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy (An Autonomous College), Moga 142001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Suri","sequence":"additional","affiliation":[{"name":"Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy (An Autonomous College), Moga 142001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9888-9826","authenticated-orcid":false,"given":"Abdulrahman","family":"Alshammari","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metab","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7569-4287","authenticated-orcid":false,"given":"Abdullah F.","family":"Alasmari","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Acharan S","family":"Narula","sequence":"additional","affiliation":[{"name":"Narula Research, LLC, 107 Boulder Bluff, Chapel Hill, NC 27516, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7764-3640","authenticated-orcid":false,"given":"Reni","family":"Kalfin","sequence":"additional","affiliation":[{"name":"Institute of Neurobiology, Bulgarian Academy of Sciences, Acad. G. Bonchev St., Block 23, 1113 Sofia, Bulgaria"},{"name":"Department of Healthcare, South-West University \u201cNeofitRilski\u201d, Ivan Mihailov St. 66, 2700 Blagoevgrad, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"ref_1","unstructured":"Ajitkumar, A., and De Jesus, O. (2021). Huntington Disease. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ejhg.2010.229","article-title":"HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia","volume":"19","author":"Warby","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000524732","article-title":"Epidemiology of Huntington\u2019s disease in the United States Medicare and Medicaid Populations","volume":"3","author":"Exuzides","year":"2022","journal-title":"Neuroepidemiology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000516767","article-title":"Modeling Manifest Huntington\u2019s Disease Prevalence Using Diagnosed Incidence and Survival Time","volume":"55","author":"Crowell","year":"2021","journal-title":"Neuroepidemiology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ajhg.2019.04.007","article-title":"Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease","volume":"104","author":"Wright","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"ref_6","first-page":"1007","article-title":"Cortico-Basal Ganglia Interactions in Huntington\u2019s","volume":"1","author":"Mehrabi","year":"2016","journal-title":"Ann. Neurodegener. Disord."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.nbd.2016.08.015","article-title":"Symptom heterogeneity in Huntington\u2019s disease correlates with neuronal degeneration in the cerebral cortex","volume":"96","author":"Mehrabi","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","article-title":"Huntington\u2019s disease and the striatal medium spiny neuron: Cell-autonomous and non-cell-autonomous mechanisms of disease","volume":"9","author":"Ehrlich","year":"2012","journal-title":"Neurotherapeutics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/7854_2014_354","article-title":"The neuropathology of Huntington\u2019s disease. Behavioral neurobiology of Huntington\u2019s disease and Parkinson\u2019s disease","volume":"22","author":"Waldvogel","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bpa.12426","article-title":"Huntington\u2019s disease (HD): The Neuropathology of a Multisystem Neurodegen-erative Disorder of the Human Brain","volume":"26","author":"Seidel","year":"2016","journal-title":"Brain Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.31887\/DCNS.2007.9.2\/arosenblatt","article-title":"Neuropsychiatry of Huntington\u2019s disease","volume":"9","author":"Rosenblatt","year":"2022","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2018.09.022","article-title":"Huntington disease: A quarter century of progress since the gene discovery","volume":"396","author":"Testa","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Roth, J. (2019). Clinical symptomatology of Huntington\u2019s disease. Pathology, Pre-Vention and Therapeutics of Neurodegenerative Disease, Springer.","DOI":"10.1007\/978-981-13-0944-1_10"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.1993.tb03633.x","article-title":"Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate","volume":"61","author":"Beal","year":"1993","journal-title":"J. Neurochem."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Naseri, N.N., Bonica, J., Xu, H., Park, L.C., Arjomand, J., Chen, Z., and Gibson, G.E. (2016). Novel metabolic abnormalities in the tricarboxylic acid cycle in peripheral cells from Huntington\u2019s disease patients. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0160384"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12291-014-0446-0","article-title":"Free radicals: Properties, sources, targets, and their implication in various diseases","volume":"30","author":"Phaniendra","year":"2015","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3164\/jcbn.16-34","article-title":"Reactive oxygen species induce neurite degeneration before induction of cell death","volume":"3","author":"Fukui","year":"2016","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neuint.2009.09.013","article-title":"Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats","volume":"56","author":"Cirillo","year":"2010","journal-title":"Neurochem. Int."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Kaur, N., Jamwal, S., Gill, H.K., and Bansal, P.K. (2017). Animal models of Huntington\u2019s disease. Animal Models of Neurological Disorders, Springer.","DOI":"10.1007\/978-981-10-5981-0_4"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1471-4159.2010.06672.x","article-title":"Differential vulnerability of neurons in Huntington\u2019s disease: The role of cell type-specific features","volume":"113","author":"Han","year":"2010","journal-title":"J. Neurochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1734-1140(10)70238-3","article-title":"Huntington\u2019s disease: Pathogenesis to animal models","volume":"62","author":"Kumar","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"ref_22","first-page":"664","article-title":"Antioxidants in Huntington\u2019s disease","volume":"1822","author":"Johri","year":"2012","journal-title":"Biochim. Bio Phys. (BBA) Mol. Basis Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fnmol.2017.00427","article-title":"Involvement of astrocytes in Alzheimer\u2019s disease from a neuroinflammatory and oxidative stress perspective","volume":"10","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.redox.2017.03.029","article-title":"Tert-buthylhydroquinone pre-conditioning exerts dual effects in old female rats exposed to 3-nitropropionic acid","volume":"12","author":"Zazueta","year":"2017","journal-title":"Redox Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1477-7827-12-126","article-title":"Reactive oxygen species and sperm DNA damage in infertile men presenting with low level leukocytospermia","volume":"12","author":"Agarwal","year":"2014","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.biopha.2016.09.070","article-title":"Chrysin exerts neuro-protective effects against 3-Nitropropionic acid induced behavioral des-pair\u2014Mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating Bax\u2014Bad genes in male wistar rats","volume":"84","author":"Thangarajan","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.apjtb.2017.05.001","article-title":"Phytochemistry and potential therapeutic actions of Boswellic acids: A mini-review","volume":"7","author":"Iram","year":"2017","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Karmarkar, S.W., Bottum, K.M., Krager, S.L., and Tischkau, S.A. (2011). ERK\/MAPK is essential for endogenous neuroprotection in SCN2. 2 cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023493"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5604\/17322693.1200553","article-title":"Frankincense-therapeutic properties","volume":"70","author":"Kiczorowska","year":"2016","journal-title":"Adv. Hyg. Exp. Med. Postep. Hig. I Med. Dosw."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Roy, N.K., Parama, D., Banik, K., Bordoloi, D., Devi, A.K., Thakur, K.K., Padmavathi, G., Shakibaei, M., Fan, L., and Sethi, G. (2019). An update on pharma-cological potential of boswellic acids against chronic diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20174101"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3892\/ijmm.2022.5130","article-title":"Focus on the role of mitochondria in NLRP3 inflammasome activation: A pro-spective target for the treatment of ischemic stroke","volume":"49","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jbm.a.37040","article-title":"PCL\/gelatin scaffolds and beta-boswellic acid synergistically increase the efficiency of CGR8 stem cells differentiation into dopaminergic neuron: A new paradigm of Parkinson\u2019s disease cell therapy","volume":"109","author":"Kheradmand","year":"2021","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9853","DOI":"10.1021\/acsomega.2c00203","article-title":"Synthesis of 3-O-acetyl-11-keto-\u03b2-boswellic acid (AKBA)-derived amides and their mitochondria-targeted antitumor activities","volume":"7","author":"Li","year":"2022","journal-title":"ACS Omega"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.34172\/PS.2020.25","article-title":"Boswellic acids as promising leads in drug development against Alzheimer\u2019s disease","volume":"27","author":"Haghaei","year":"2020","journal-title":"Pharm. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/jnnp-2017-317101","article-title":"standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)","volume":"89","author":"Stellmann","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1007\/s12035-022-02848-w","article-title":"Beta-Boswellic Acid Protects Against Cerebral Ischemia\/Reperfusion Injury via the Protein Kinase C Epsilon\/Nuclear Factor Erythroid 2-like 2\/Heme Ox-ygenase-1 Pathway","volume":"59","author":"Wang","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_37","first-page":"277","article-title":"Genus Boswellia as a new candidate for neurodegenerative disorders","volume":"23","author":"Rajabian","year":"2020","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_38","first-page":"1098","article-title":"Excitotoxicity, neuroinflammation and oxidant stress as molecular bases of epileptogenesis and epilepsy-derived neurodegeneration: The role of vitamin E","volume":"1865","author":"Ambrogini","year":"2019","journal-title":"Biochim. Bio Phys. (BBA) Mol. Basis Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cger.2009.12.003","article-title":"Potential future neuroprotective therapies for neurodegenerative disorders and stroke","volume":"26","author":"Tarawneh","year":"2010","journal-title":"Clin. Geriatr. Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Gupta, R., Mehan, S., Sethi, P., Prajapati, A., Alshammari, A., Alharbi, M., Al-Mazroua, H.A., and Narula, A.S. (2022). Smo-Shh agonist Purmorphamine prevents neurobehavioral and neurochemical defects in 8-OH-DPAT-induced experimental model of obsessive-compulsive disorder. Brain Sci., 12.","DOI":"10.3390\/brainsci12030342"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/ADR-190125","article-title":"Neuroprotective approach of anti-cancer microtubule stabilizers against tauopathy associated dementia: Current status of clinical and preclinical findings","volume":"3","author":"Duggal","year":"2019","journal-title":"J. Alzheimer\u2019s Dis. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"105067","DOI":"10.1016\/j.neuint.2021.105067","article-title":"Targeting PI3K-AKT\/mTOR signaling in the prevention of autism","volume":"147","author":"Sharma","year":"2021","journal-title":"Neurochem. Int."},{"key":"ref_43","first-page":"68","article-title":"Neuroprotection of brain permeable Forskolin ameliorates behavioral, biochemical and histopatho-logical alterations in rat model of intracerebral hemorrhage","volume":"10","author":"Dudi","year":"2018","journal-title":"Pharmaspire"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1573407216999200723113054","article-title":"Neuroprotective potential of ade-nylcyclase\/cAMP\/CREB and mitochondrial CoQ10 activator in amyotrophic lateral sclerosis rats","volume":"17","author":"Alam","year":"2021","journal-title":"Curr. Bioact. Compd."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.4103\/1673-5374.270316","article-title":"Adenylatecyclase activator forskolin alleviates intracerebroventricular propionic acid-induced mitochondrial dysfunction of autistic rats","volume":"15","author":"Mehan","year":"2020","journal-title":"Neural Regen. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ibror.2020.03.001","article-title":"Neuroprotective potential of solanesol in a combined model of intracerebral and intraventricular hemor-rhage in rats","volume":"8","author":"Rajdev","year":"2020","journal-title":"IBRO Rep."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Mehan, S., Khera, H., and Sharma, R. (2019). Neuroprotective Strategies of Blood-Brain Barrier Penetrant \u201cForskolin\u201d (AC\/cAMP\/PKA\/CREB Activator) to Ameliorate Mitochondrial Dysfunctioning in Neurotoxic Experimental Model of Autism. Recent Advances in Neurodegeneration, IntechOpen.","DOI":"10.5772\/intechopen.80046"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.toxrep.2019.10.019","article-title":"Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: Insights from behavioral and biochemical evidence","volume":"6","author":"Sharma","year":"2019","journal-title":"Toxicol. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1016\/j.sjbs.2021.07.010","article-title":"Neuroprotective efficacy of 4-Hydroxyisoleucine in experimentally induced intracerebral hemorrhage","volume":"28","author":"Siddiqui","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Shandilya, A., Mehan, S., Kumar, S., Sethi, P., Narula, A.S., Alshammari, A., Alharbi, M., and Alasmari, A.F. (2022). Activation of IGF-1\/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity. Molecules, 27.","DOI":"10.3390\/molecules27123878"},{"key":"ref_51","first-page":"45","article-title":"Neuroprotective effect of ellagic acid against chronically scopolamine induced Alzheimer\u2019s type memory and cognitive dysfunctions: Possible behavioural and biochemical evidences","volume":"1","author":"Kaur","year":"2015","journal-title":"Int. J. Preven. Med. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1177\/09603271211013456","article-title":"Smo-Shh signaling activator purmor-phamine ameliorates neurobehavioral, molecular, and morphological alterations in an intracerebroventricular propionic acid-induced experimental model of autism","volume":"40","author":"Rahi","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"72881","DOI":"10.1039\/C5RA13160J","article-title":"Experimental evidence for the potential of lycopene in the management of scopolamine induced amnesia","volume":"5","author":"Bala","year":"2015","journal-title":"RSC Adv."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.toxrep.2022.04.023","article-title":"Effect of alpha-mangostin in the prevention of behavioural and neurochemical defects in methylmercury-induced neurotoxicity in ex-perimental rats","volume":"9","author":"Sahu","year":"2022","journal-title":"Toxicol. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s10020-018-0020-y","article-title":"Effects of CREB1 gene silencing on cognitive dysfunc-tion by mediating PKA-CREB signaling pathway in mice with vascular de-mentia","volume":"24","author":"Han","year":"2018","journal-title":"Mol. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2009.08.027","article-title":"Amelioration of in-tracerebroventricularstreptozotocin induced cognitive dysfunction and oxi-dative stress by vinpocetine\u2014A PDE1 inhibitor","volume":"620","author":"Deshmukh","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4103\/1673-5374.200812","article-title":"Adenylcyclase activator forskolin protects against Huntington\u2019s disease-like neurodegenerative disorders","volume":"12","author":"Mehan","year":"2017","journal-title":"Neural Re-Gener. Res."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Khera, R., Mehan, S., Bhalla, S., Kumar, S., Alshammari, A., Alharbi, M., and Sadhu, S.S. (2022). Guggulsterone mediated JAK\/STAT and PPAR-gamma modulation prevents neurobehavioral and neurochemical abnormalities in propionic acid-induced experimental model of autism. Molecules, 27.","DOI":"10.3390\/molecules27030889"},{"key":"ref_59","first-page":"1143","article-title":"Boswellic acids: Novel, specific, nonredox inhibitors of 5-lipoxygenase","volume":"261","author":"Safayhi","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/molecules15020878","article-title":"3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington\u2019s disease: Past, present and future","volume":"15","author":"Tasset","year":"2010","journal-title":"Molecules"},{"key":"ref_61","unstructured":"Jinu, A. (2020). Elucidation of Role of 3-O-Acetyl-11-Keto-\u03b2-Boswellic Acid (AKBA) on Peroxisome Proliferator-Activated Receptor-\u03b3 in Scopolamine Induced Cognitive Impairment Model in Rats. [Ph.D. Thesis, KMCH College Of Pharmacy]."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1007\/s11064-021-03366-2","article-title":"Nrf2\/HO-1 signaling activator ace-tyl-11-keto-beta Boswellic acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-induced experimental model of ALS","volume":"46","author":"Minj","year":"2021","journal-title":"Neurochem. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2217\/nmt.13.22","article-title":"Characteristics, pathophysiology and clinical manage-ment of weight loss in Huntington\u2019s disease","volume":"3","author":"Aziz","year":"2013","journal-title":"Neurodegener. Dis. Manag."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Kim, H.S., and Song, J. (2015). Cell therapy in Huntington\u2019s disease. Progress in Stem Cell Transplantation, IntechOpen.","DOI":"10.5772\/60618"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/eji.201343629","article-title":"Boswellic acids reduce T h17 differentiation via blockade of IL-1\u03b2-mediated IRAK 1 signaling","volume":"44","author":"Verse","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"7468064","DOI":"10.1155\/2017\/7468064","article-title":"Antioxidant and ex vivo immune systemregulatory properties of Boswelliaserrata extracts","volume":"2017","author":"Beghelli","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/biof.195","article-title":"Vitamin E in aging, dementia, and Alzheimer\u2019s disease","volume":"38","author":"Joshi","year":"2012","journal-title":"Biofactors"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"9160","DOI":"10.1073\/pnas.1220068110","article-title":"Huntington disease skeletal muscle is hyperexcitable owing to chloride and potassium channel dysfunction","volume":"110","author":"Waters","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"506952","DOI":"10.1155\/2010\/506952","article-title":"Forebrain ischemia triggers GABAergic system degeneration in substantia nigra at chronic stages in rats","volume":"2010","author":"Lin","year":"2010","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1172\/JCI119783","article-title":"Nitric oxide in excitable tissues: Physiological roles and disease","volume":"100","author":"Christopherson","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxiclesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001756-199301000-00019","article-title":"Age dependence of striatalneuronal death caused by mitochondrial dysfunction","volume":"4","author":"Bossi","year":"1993","journal-title":"Neuroreport"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/em.20575","article-title":"Mitochondrial dysfunction in neurodegenerative diseases and cancer","volume":"51","year":"2010","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/1389201011314030011","article-title":"Targeting the mitochondrial electron transport chain complexes for the induction of apoptosis and cancer treatment","volume":"14","author":"Rohlena","year":"2013","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/a-1502-7083","article-title":"Protection of Beta Boswellic Acid against Streptozotocin-induced Alzheimer\u02bcs Model by Reduction of Tau Phosphorylation Level and Enhancement of Reelin Expression","volume":"88","author":"Shasaltaneh","year":"2022","journal-title":"Planta Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.tox.2007.11.003","article-title":"Protective effect of minocycline, a semisynthetic second generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity","volume":"244","author":"Ahuja","year":"2008","journal-title":"Toxicology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cns.12655","article-title":"Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: Pathogenesis and treatment","volume":"23","author":"Golpich","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1476-5381.2011.01418.x","article-title":"Role of LOX\/COX pathways in 3-nitropropionicacid-induced Huntington\u2019s disease-like symptoms in rats: Protective effect of licofenole","volume":"162","author":"Kumar","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2004.02.004","article-title":"Effect of glucocorticoids on 3-nitropropionic acid-induced oxidativestressing synaptosomes","volume":"488","author":"Montilla","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.lfs.2016.06.027","article-title":"Neurochemical correlation between major depressive disorder and neuro-degenerative diseases","volume":"158","author":"Reus","year":"2016","journal-title":"Life Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2525967","DOI":"10.1155\/2017\/2525967","article-title":"Oxidative stress in neuro-degenerative diseases: From molecular mechanisms to clinical applications","volume":"2017","author":"Liu","year":"2017","journal-title":"Oxidative Med. Cell Longev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/mds.26012","article-title":"Determinants of functional disability in Huntington\u2019s disease: Role of cognitive and motor dysfunction","volume":"29","author":"Ross","year":"2014","journal-title":"Mov. Disord."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41583-021-00428-w","article-title":"Cognitive and behavioural flexibility: Neural mechanisms and clinical considerations","volume":"22","author":"Uddin","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13670-011-0005-y","article-title":"Cognitive deficits in Huntington\u2019s disease: Insights from animal models","volume":"1","author":"Wang","year":"2012","journal-title":"Curr. Transl. Geriatr. Exp. Gerontol. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Sas, K., Szab\u00f3, E., and V\u00e9csei, L. (2018). Mitochondria, oxidative stress and the kynurenine system, with a focus on ageing and neuroprotection. Molecules, 23.","DOI":"10.3390\/molecules23010191"},{"key":"ref_86","first-page":"1132","article-title":"Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neuro-degeneration","volume":"1863","author":"Jha","year":"2017","journal-title":"Biochim. Bio Phys. (BBA) Mol. Basis Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1196\/annals.1427.027","article-title":"Mitochondrial approaches for neuroprotection","volume":"1147","author":"Chaturvedi","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000334273","article-title":"N-Acetylcysteine reverses mito-chondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington\u2019s disease","volume":"9","author":"Sandhir","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Pal, A., and Das, S. (2019). Terpenoids in Treatment of Neurodegenerative Disease. Terpenoids Against Human Diseases, CRC Press.","DOI":"10.1201\/9781351026703-5"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/B978-0-444-63425-2.00010-6","article-title":"The role of dopamine in Huntington\u2019s disease","volume":"211","author":"Cepeda","year":"2014","journal-title":"Prog. Brain Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2991\/efood.k.200203.001","article-title":"Dietary flavonoids in the management of huntington\u2019s disease: Mechanism and clinical perspective","volume":"1","author":"Khan","year":"2020","journal-title":"EFood"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.7150\/ijms.36516","article-title":"Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases","volume":"16","author":"Tabassum","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1038\/emm.2014.122","article-title":"The role of mitochondrial DNA mutation on neurodegenerative diseases","volume":"47","author":"Cha","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.brainresbull.2012.01.003","article-title":"Probucol modulates oxidative stress and excitotoxicity in Huntington\u2019s disease models in vitro","volume":"87","author":"Colle","year":"2012","journal-title":"Brain Res. Bull."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"110368","DOI":"10.1016\/j.pnpbp.2021.110368","article-title":"Nano-ivabradine averts behavioral anomalies in Huntington\u2019s disease rat model via modulat-ingRhes\/m-tor pathway","volume":"111","author":"Saad","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Bio-Log. Psychiatry"},{"key":"ref_97","first-page":"104548","article-title":"Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington\u2019s disease model rats via modulation of the calcium\/calcineurin\/NFATc4 and Wnt\/\u03b2-catenin signalling pathways","volume":"131","author":"Elbaz","year":"2019","journal-title":"Neuro-Chem. Int."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"118076","DOI":"10.1016\/j.lfs.2020.118076","article-title":"Dapagliflozinim-proves behavioral dysfunction of Huntington\u2019s disease in rats via inhibiting apoptosis-related glycolysis","volume":"257","author":"Rastanawi","year":"2020","journal-title":"Life Sci."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/11\/2866\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:13:16Z","timestamp":1760145196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/11\/2866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":98,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["biomedicines10112866"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10112866","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]}}}